Redwood Pharma to Attend ARVO in Honolulu, April 30 – May 3, 2018
Redwood Pharma will attend the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Honolulu, Hawaii to meet with prospective commercialization partners for RP101, the Company’s unique treatment for chronic dry eye disease in postmenopausal women.ARVO’s Annual Meeting is arguably the largest conference that brings together 11,000 international basic and clinical researchers that share the latest breakthroughs in vision research. Redwood Pharma CEO Martin Vidaeus states, ”We are looking forward to making further contacts with researchers and pharmaceutical firms in